New Zealand markets open in 10 minutes
  • NZX 50

    12,211.96
    +82.98 (+0.68%)
     
  • NZD/USD

    0.6307
    -0.0023 (-0.36%)
     
  • ALL ORDS

    7,740.50
    +27.40 (+0.36%)
     
  • OIL

    78.48
    +1.34 (+1.74%)
     
  • GOLD

    1,886.70
    +1.90 (+0.10%)
     

Stem Cell Technologies and Applications Market Report 2022-2032

ReportLinker
ReportLinker

Forecasts by Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), by Cell Source (Adipose Tissue-derived MSCs, Bone Marrow-derived MSCs, Placental/Umbilical Cord-derived MSCs), by Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture, Other), by Application (Cancer, Cardiovascular Diseases, Neurological Disorders, Inflammatory and Autoimmune Diseases, Musculoskeletal Disorders, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis.

New York, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Stem Cell Technologies and Applications Market Report 2022-2032" - https://www.reportlinker.com/p06371545/?utm_source=GNW


The Stem Cell Technologies and Applications Market Report 2022-2032: This report will prove invaluable to leading firms striving for the new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.


Rise in Stem Cell Clinical Trials

Recent years have seen a significant expansion in both stem cell research and the clinical use of these promising cells. The National Institute for Health (NIH) database reported a total of 374 registered clinical trials of which unknown status were not considered. It shows that there has been 3 times expansion in the total number of clinical trials conducted since 2011.Clinical experiments using stem cells have changed the course of the developing field in recent years. While many teams continue to develop and broaden the role of bone marrow and cord blood stem cells for their cutting-edge applications in immune and blood disorders, many others are seeking to expand the applications of the various stem cell types found in bone marrow and cord blood, particularly mesenchymal stem cells, to uses beyond those that could be resolved by replacing cells in their own lineage. Other adult stem cell types, particularly brain stem cells, are being used more frequently by research teams to treat disorders where either in-lineage cell replacement or extracellular factors may have a positive impact. The majority of MSC trials are with allogenic cells and these trials are being conducted globally with largest activity witnessed in U.S., Europe and China. However, despite increase in clinical trials and significant investments being made for conducting these trials the commercialization of these trials have been slow and is a matter of concern for all the shareholders of this industry


What Questions Should You Ask before Buying a Market Research Report?

• How is the stem cell technologies and applications market evolving?

• What is driving and restraining the stem cell technologies and applications market?

• How will each stem cell technologies and applications submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?

• How will the market shares for each stem cell technologies and applications submarket develop from 2022 to 2032?

• What will be the main driver for the overall market from 2022 to 2032?

• Will leading stem cell technologies and applications markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?

• Who are the leading players and what are their prospects over the forecast period?

• What are the stem cell technologies and applications projects for these leading companies?

• How will the industry evolve during the period between 2020 and 2032? What are the implications of stem cell technologies and applications projects taking place now and over the next 10 years?

• Is there a greater need for product commercialization to further scale the stem cell technologies and applications market?

• Where are the stem cell technologies and applications market heading and how can you ensure you are at the forefront of the market?

• What are the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path and C-suite?


You need to discover how this will impact the stem cell technologies and applications market today, and over the next 10 years:

• Our 355-page report provides 170 tables and 221 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.


This report tells you TODAY how the stem cell technologies and applications market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.


Forecasts to 2032 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising stem cell technologies and applications prices and recent developments.


This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.


Segments Covered in the Report


Market Segment by Type

• Allogeneic Stem Cell Therapy

• Autologous Stem Cell Therapy


Market Segment by Cell Source

• Adipose tissue-derived MSCs

• Bone marrow-derived MSCs

• Placental/umbilical cord-derived MSCs


Market Segment by Product

• Adult Stem Cells

• Human Embryonic Stem Cells

• Induced Pluripotent Stem Cells

• Very Small Embryonic Like Stem Cells


Market Segment by Technology

• Cell Acquisition

• Cell Production

• Cryopreservation

• Expansion and Sub-Culture

• Other Technology


Market Segment by Application

• Cancer

• Cardiovascular Diseases

• Neurological Disorders

• Inflammatory and Autoimmune Diseases

• Musculoskeletal Disorders

• Other Applications


In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:


North America

• U.S.

• Canada


Europe

• Germany

• Spain

• United Kingdom

• France

• Italy

• Rest of Europe


Asia Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia Pacific


Latin America

• Brazil

• Mexico

• Rest of Latin America


Middle East and Africa

• Turkey

• South Africa

• UAE

• Rest of the Middle East and Africa


The report also includes profiles and for some of the leading companies in the Stem Cell Technologies and Applications Market, 2022 to 2032, with a focus on this segment of companies’ operations.


Leading companies and the potential for market growth

• Athersys, Inc.

• Biorestorative Therapies, Inc.

• BrainStorm Cell Limited

• Cellaïon SA

• Cellular Biomedicine Group, Inc.

• Cynata Therapeutics Limited

• Gamida Cell Ltd.

• Kangstem Biotech Co., Ltd.

• Mesoblast Limited

• Pluristem Therapeutics Inc.

• Plus Therapeutics, Inc.

• Sangamo Therapeutics, Inc.

• StemCell Technologies Inc.

• Vericel Corporation

• ViaCyte, Inc.


Overall world revenue for Stem Cell Technologies and Applications Market, 2022 to 2032 in terms of value the market will surpass US$9,922 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.


How will the Stem Cell Technologies and Applications Market, 2022 to 2032 report help you?

In summary, our 350+ page report provides you with the following knowledge:


• Revenue forecasts to 2032 for Stem Cell Technologies and Applications Market, 2022 to 2032 Market, with forecasts for type, cell source, product, technology, application, and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.


• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Stem Cell Technologies and Applications Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.


• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Stem Cell Technologies and Applications Market, 2022 to 2032.


Read the full report: https://www.reportlinker.com/p06371545/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001